Study to Evaluate the Pharmacokinetic Profile of Salbutamol Delivered by Unit Dose Dry Powder Inhaler (UD-DPI) Compared to the Diskus and Metered Dose Inhaler (MDI) in Healthy Volunteers.

NCT01984086 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Salbutamol Sulphate 150mcg UD-DPI Blister(1.6% blend)
DRUG: Salbutamol Sulphate 200mcg UD-DPI Blister(1.6% blend)
DRUG: Salbutamol Sulphate 250mcg UD-DPI Blister(1.6% blend)
DRUG: Salbutamol Sulphate 200mcg UD-DPI Blister(1% blend)
DRUG: Salbutamol Diskus 200mcg Blister
DRUG: Salbutamol MDI 100mcg
DRUG: Salbutamol Sulphate UD-DPI Blister (selected from Part A)
DRUG: Salbutamol Sulphate 250mcg UD-DPI Blister (selected from Part A)
DRUG: Salbutamol Diskus 200mcg Blister without activated charcoal
DRUG: Salbutamol Diskus 200mcg Blister with activated charcoal
DRUG: Salbutamol MDI 100mcg without activated charcoal
DRUG: Salbutamol MDI 100mcg with activated charcoal

Sponsor

GlaxoSmithKline